Document is current
Any future updates will be listed below
-
Authors
Pfeiffer, Kathryn M. https://orcid.org/0000-0003-2186-6340
Brod, Meryl https://orcid.org/0000-0002-0663-5838
Smith, Alden https://orcid.org/0000-0003-1582-534X
Viuff, Dorthe
Ota, Sho https://orcid.org/0000-0001-5786-8423
Charlton, R. Will https://orcid.org/0000-0001-8451-9165
-
Funding
Funding for this research was provided by:
Ascendis Pharma Growth Disorders, A/S
- License Information
-
More Information
Article History
Received: 17 February 2021
Accepted: 25 July 2021
First Online: 6 August 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Copernicus Group Institutional Review Board, Protocol numbers: TBG1-18–117 and 20190578) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all parent participants included in the study.
: Not applicable.
: K. Pfeiffer and M. Brod are paid consultants to the pharmaceutical industry, including Ascendis Pharma. A. Smith is an employee of Ascendis Pharma, Inc. D. Viuff is an employee of Ascendis Pharma, A/S. R.W. Charlton and S. Ota were employees of Ascendis Pharma, Inc. at the time this research was conducted<b>.</b>
